Is a complete SHE/301281 research report available?

No complete published report is available for she/301281 (SHE/301281) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

she/301281 stock profile: metrics, valuation and analysis

Market cap	5.1B
Revenue (ttm)	501.8M
Net income (ttm)	38.6M
EPS (ttm)	CN¥0.35
Shares out	108.3M
P/E (trailing)	133.8x
Dividend	CN¥0.05 (0.11%)
Volume	1,975,184
Beta	0.19

All SHE/301281 indicators

Market & fundamental data

Available fields

214

Groups with data

Currency

CNY

Showing 214 of 214 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	650
Employees Change	-46%
Employees Change Percent	-6.61
Enterprise value	CNY 5B
Exchange	Shenzhen Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Drug Manufacturers - General
Industry PE	43.63
Isin	CNE1000061V8
Last refreshed	2026-09-07
Market cap	CNY 5.1B
Price	CNY 46.76
Price currency	CNY
Rev Per Employee	772,043.54x
Sector	Healthcare
Sector PE	40.46
Sector PE Fwd	21.02
Sic	2834
Symbol	she/301281
Website	https://www.keyuanpharm.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	0.76%
EV Earnings	130.32x
EV/EBIT	85.03x
EV/EBITDA	45.3x
EV/Sales	10.01x
FCF yield	-1%
P/B ratio	3.54x
P/E ratio	133.82x
P/S ratio	10.09x
PE Ratio3 Y	80.31x
PE Ratio5 Y	76.54x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	11.78%
EBITDA Margin	22.1%
Gross margin	51.62%
Gross Profit	CNY 259.1M
Gross Profit Growth	16.1%
Gross Profit Growth Q	41.46%
Gross Profit Growth3 Y	8.2%
Gross Profit Growth5 Y	21.21%
Net Income	CNY 38.6M
Net Income Growth	-42.48%
Net Income Growth Q	76.64%
Net Income Growth Qo Q	15.11%
Net Income Growth3 Y	-25%
Net Income Growth5 Y	-2.73%
Pretax Margin	9.1%
Profit Margin	7.68%
Profit Per Employee	CNY 59,326
ROA	2.1
Roa5y	5.03
ROCE	3.74
ROE	2.72
Roe5y	10.69
ROIC	3.84
Roic5y	12.27

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	32.4%
Cagr3y	2.58%
EPS Growth	-43.74
EPS Growth Q	76.63
EPS Growth Qo Q	15.12
EPS Growth3 Y	-30.38
EPS Growth5 Y	-8.58
OCF Growth Q	-57.37%
OCF Growth Qo Q	-64.22%
OCF Growth3 Y	-14.43%
OCF Growth5 Y	40.74%
Revenue Growth	10.43x
Revenue Growth Q	45.86x
Revenue Growth Qo Q	5.49x
Revenue Growth3 Y	4.23x
Revenue Growth5 Y	13.93x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.29
Assets	CNY 1.9B
Cash	CNY 241.8M
Current Assets	CNY 764.3M
Current Liabilities	CNY 332M
Debt	CNY 203M
Debt EBITDA	CNY 1.83
Debt Equity	CNY 0.14
Debt FCF	CNY -4
Equity	CNY 1.4B
Liabilities	CNY 481.1M
Long Term Assets	CNY 1.1B
Long Term Liabilities	CNY 149.1M
Net Cash	CNY 38.8M
Net Cash By Market Cap	CNY 0.77
Net Cash Growth	-85.77%
Net Debt EBITDA	CNY -0.35
Net Debt Equity	CNY -0.03
Tangible Book Value	CNY 1.2B
Tangible Book Value Per Share	CNY 11.4
WACC	5.07

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.3
Inventory Turnover	1.77
Net Working Capital	CNY 273.1M
Quick ratio	1.53
Working Capital	CNY 432.3M
Working Capital Turnover	CNY 1.02

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-2.24%
Dividend Growth	-75%
Dividend Growth Years	0%
Dividend per share	CNY 0.05
Dividend Years	4
Dividend Yield	0.11%
Ex Div Date	2026-06-16
Last Dividend	CNY 0.05
Payout Frequency	Annual
Payout Ratio	29.3%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	32.37%
200-day SMA	38.63
3Y total return	7.94%
50-day SMA	43.69
50-day SMA vs 200-day SMA	50over200
All Time High	63.99
All Time High Change	-26.93%
All Time High Date	2023-08-14
All Time Low	18.52
All Time Low Change	152.48%
All Time Low Date	2024-09-18
ATR	2.68
Beta	0.19
Beta1y	1.34
Beta2y	0.84
Ch YTD	59.59
High	48.62
High52	59.24
High52 Date	2026-07-02
High52ch	-21.07%
Low	45.96
Low52	25.87
Low52 Date	2025-12-17
Low52ch	80.75%
Ma50ch	7.03%
Price vs 200-day SMA	21.06%
RSI	57.78
RSI Monthly	57.26
RSI Weekly	56.09
Sharpe ratio	0.61x
Sharpe Ratio3y	0.55x
Sortino ratio	1.02
Sortino Ratio3y	1.01
Total Return	-2.13%
Tr YTD	59.75
Tr1m	31.9%
Tr1w	-2.99%
Tr3m	4.78%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	50,093,500%
Net Borrowing	98,219,049
Shares Insiders	4.88%
Shares Institutions	4.51%
Shares Out	108,290,000
Shares Qo Q	-0.01%
Shares Yo Y	2.24%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	2,751,199.3x
Bv Per Share	13.2
CAPEX	CNY -110.9M
Ch1m	31.9
Ch1w	-2.99
Ch1y	32.24
Ch3m	4.68
Ch3y	5.94
Ch6m	12.78
Change	-1.56%
Change From Open	-3.03
Close	47.5
Days Gap	1.52
Depreciation Amortization	51,820,267
Dollar Volume	92,359,603.8
Earnings Date	2026-08-27
EBIT	CNY 59.1M
EBITDA	CNY 110.9M
EPS	CNY 0.35
F Score	5
FCF	CNY -50.8M
FCF EV Yield	-1.01x
FCF Per Share	CNY -0.47
Financing CF	86,920,015
Fiscal Year End	December
Founded	2,004
Goodwill	1,025,455
Graham Number	10.18781
Graham Upside	-78.21
Income Tax	CNY 7.5M
Investing CF	-182,575,690
Is Primary Listing	1
Last Earnings Date	2026-08-27
Last Report Date	2026-06-30
Last Split Date	2023-05-26
Last Split Type	Forward
Lynch Fair Value	CNY 1.75
Lynch Upside	-96.26
Ma150	41.74
Ma150ch	12.02%
Ma20	44.97
Ma20ch	3.98%
Net CF	-36,307,189
Next Earnings Date	2026-10-23
Open	48.22
P OCF Ratio	84.17
Payment Date	2026-06-16
Position In Range	30.08
Ppne	691,443,163
Price Date	2026-09-04
Price EBITDA	CNY 45.65
Ptbv Ratio	4.1
Relative Volume	0.72x
Revenue	501,828,303x
Tax By Revenue	1.49x
Tax Rate	16.34%
Tr6m	12.9%
Volume	1,975,184

SHE/301281 (SHE/301281)

Price

Financial snapshot

Fair-value bridge

Latest news · SHE/301281

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All SHE/301281 indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on SHE/301281

Frequently asked questions